Gamida Cell Reports First Quarter 2020 Financial Results and Provides Company Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/22/2026

1. SPCX
2. NVDA
3. NFLX
4. ISRG
5. TSLA
6. META
7. SMCI
8. RTX
9. GOOGL
10. S

Go back to Gamida Cell Reports First Quarter 2020 Financial Results and Provides Company Update

Gamida Cell Ltd. (GMDA) Tops Q1 EPS by 14c

May 21, 2020 8:02 AM EDT

Gamida Cell Ltd. (NASDAQ: GMDA) reported Q1 EPS of ($0.31), $0.14 better than the analyst estimate of ($0.45).

First Quarter 2020 Financial Results

Research and development expenses in the first quarter of 2020 were $7.9 million, compared to $7.3 million for the same period in 2019. The increase was mainly due to clinical activities relating to the advancement GDA-201, offset by grants received from the Israel Innovation Authority.Commercial expenses in the first quarter of 2020 were $1.5 million compared to $1.0 million for the same period in 2019. The increase was mainly attributed to commercial readiness activities for omidubicel.General and... More